Problems of management of heart failure patients of older age groups

1. Мареев В.Ю., Фомин И.В., Агеев Ф.Т. и др. Клинические рекомендации. Хроническая сердечная недостаточность (ХСН) // Сердечная Недостаточность. 2017. № 18 (1). С.3–40 [Mareev V. Ju., Fomin I.V., Ageev F.T. i dr. Klinicheskie rekomendacii. Hronicheskaja serdechnaja nedostatochnost' (HSN) // Serdechnaja Nedostatochnost'. 2017. № 18 (1). S.3–40 (in Russian)]. 2. Writing Group Members, Mozaffarian D., Benjamin E.J. et al. American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association // Circulation. 2016. Vol. 133 (4). P.447–454. 3. Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать // Российский кардиологический журнал. 2016. № (8). С.7–13 [Fomin I.V. Hronicheskaja serdechnaja nedostatochnost' v Rossijskoj Federacii: chto segodnja my znaem i chto dolzhny delat' // Rossijskij kardiologicheskij zhurnal. 2016. № (8). S.7–13 (in Russian)]. 4. Chaudhry S.I., Wang Y., Gill T.M., Krumholz H.M. Geriatric conditions and subsequent mortality in older patients with heart failure // J. Am. Coll. Cardiol. 2010. Vol. 55. P.309–316. 5. Morley J.E., Vellas B., van Kan G.A. et al. Frailty consensus: a call to action // J. Am. Med. Dir. Assoc. 2013. Vol. 14. P.392–397. 6. Afilalo J., Alexander K.P., Mack M.J. et al. Frailty assessment in the cardiovascular care of older adults // J. Am. Coll. Cardiol. 2014. Vol. 63. P.747–762. 7. Ткачева О.Н., Котовская Ю.В., Остапенко В.С. Особенности клинических подходов к ведению пациентов со старческой астенией // РМЖ. 2017. Т.25. № 25. С.1823–1825 [Tkacheva O.N., Kotovskaja Ju.V., Ostapenko V.S. Osobennosti klinicheskih podhodov k vedeniju pacientov so starcheskoj asteniej // RMZh. 2017. T.25. № 25. S.1823–1825 (in Russian)]. 8. McNallan S.M., Chamberlain A.M., Gerber Y. et al. Measuring frailty in heart failure: a community perspective // Am. Heart J. 2013. Vol. 166. P.768–774. 9. Uchmanowicz I., Łoboz-Rudnicka M., Szeląg P. et al. Frailty in Heart Failure // Curr. Heart Fail Rep. 2014. Vol. 11 (3). P.266–273. 10. Kleipool E.E., Hoogendijk E.O., Trappenburg M.C. et al. Frailty in Older Adults with Cardiovascular Disease: Cause, Effect or Both? // Aging Dis. 2018. Vol. 9 (3). P.489–497. 11. Fried L.P., Tangen C.M., Walston J. et al. Frailty in older adults: evidence for a phenotype // J. Gerontol. A Biol. Sci. Med. Sci. 2001. Vol. 56. P. M146–M156. 12. Ткачева О.Н., Рунихина Н.К., Остапенко В.С. и соавт. Валидация опросника для скрининга синдрома старческой астении в амбулаторной практике // Успехи геронтологии. 2017. № 2. С.236–242 [Tkacheva O.N., Runihina N.K., Ostapenko V.S. i soavt. Validacija oprosnika dlja skrininga sindroma starcheskoj astenii v ambulatornoj praktike // Uspehi gerontologii. 2017. № 2. S.236–242 (in Russian)]. 13. EMA — Reflection paper on physical frailty, 2018. [Электронный ресурс]. URL: http://www.eugms.org/news/read/article/374.html (дата обращения: 22.10.2018). 14. Altimir S., Lupon J., Gonzalez B. et al. Sex and age differences in fragility in a heart failure population // Eur. J. Heart Fail. 2005. Vol. 7. P.798–802. 15. Khan H., Kalogeropoulos A.P., Georgiopoulou V.V. et al. Frailty and risk for heart failure in older adults: the health, aging, and body composition study // Am. Heart J. 2013. Vol. 166. P.887–894. 16. Newman A.B., Gottdiener J.S., McBurnie M.A. et al. Associations of subclinical cardiovascular disease with frailty // J. Gerontol. A Biol. Sci. Med. Sci. 2001. Vol. 56. P. M158–M166. 17. Woods N.F., LaCroix A.Z., Gray S.L. et al. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study // J. Am. Geriatr. Soc. 2005. Vol. 53. P.1321–1330. 18. Jencks S.F., Williams M.V., Coleman E.A. Rehospitalizations among patients in the Medicare fee-for-service program // N. Engl. J. Med. 2009. Vol. 360. P.1418–1428. 19. Braunstein J.B., Anderson G.F., Gerstenblith G. et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure // J. Am. Coll. Cardiol. 2003. Vol. 42. P.1226–1233. 20. Walston J., McBurnie M.A., Newman A. et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study // Arch. Intern. Med. 2002. Vol. 162. P.2333–2341. 21. Chang S.S., Weiss C.O., Xue Q.L., Fried L.P. Association between inflammatory-related disease burden and frailty: results from the Women's Health and Aging Studies (WHAS) I and II // Arch. Gerontol. Geriatr. 2012. Vol. 54. P.9–15. 22. Varadhan R., Chaves P.H., Lipsitz L.A. et al. Frailty and impaired cardiac autonomic control: new insights from principal components aggregation of traditional heart rate variability indices // J. Gerontol. A Biol. Sci. Med. Sci. 2009. Vol. 64. P.682–687. 23. Baumgartner R.N., Koehler K.M., Gallagher D. et al. Epidemiology of sarcopenia among the elderly in New Mexico // Am. J. Epidemiol. 1998. Vol. 147. P.755–763. 24. Fulster S., Tacke M., Sandek A. et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF) // Eur. Heart. J. 2013. Vol. 34. P.512–519. 25. Anker S.D., Laviano A., Filippatos G. et al. ESPEN guidelines on parenteral nutrition: on cardiology and pneumology // Clin. Nutr. 2009. Vol. 28. P.455–460. 26. Anker S.D., Ponikowski P., Varney S. et al. Wasting as independent risk factor for mortality in chronic heart failure // Lancet. 1997. Vol. 349. P.1050–1053. 27. Ather S., ChanW., Bozkurt B. et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction // J. Am. Coll. Cardiol. 2012. Vol. 59. P.998–1005. 28. Wong C.H., Weiss D., Sourial N. et al. Frailty and its association with disability and comorbidity in a community-dwelling sample of seniors in Montreal: a cross-sectional study // Aging Clin. Exp. Res. 2010. Vol. 22. P.54–62. 29. Kelaiditi E., Cesari M., Canevelli M. et al. Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group // J. Nutr. Health Aging. 2013. Vol. 17. P.726–734. 30. Nguyen H.T., Black S.A., Ray L.A. et al. Cognitive impairment and mortality in older mexican Americans // J. Am. Geriatr. Soc. 2003. Vol. 51. P.178–183. 31. Zuccala G., Marzetti E., Cesari M. et al. Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey // Am. J. Med. 2005. Vol. 118. P.496–502. 32. Vogels R.L., Scheltens P., Schroeder-Tanka J.M., Weinstein H.C. Cognitive impairment in heart failure: a systematic review of the literature // Eur. J. Heart Fail. 2007. Vol. 9. P.440–449. 33. Laurence B.D., Michel L. The Fall in Older Adults: Physical and Cognitive Problems // Curr. Aging Sci. 2017. Vol. 10 (3). P.185–200. 34. Persad C.C., Jones J.L., Ashton-Miller J.A. et al. Executive function and gait in older adults with cognitive impairment // J. Gerontol. A Biol. Sci. Med. Sci. 2008. Vol. 63. P.1350–1355. 35. Murad K., Kitzman D.W. Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management // Heart Fail Rev. 2012. Vol. 17. P.581–588. 36. Орлова Я.А., Ткачева О.Н., Арутюнов Г.П., Котовская Ю.В. Особенности диагностики и лечения хронической сердечной недостаточности у пациентов пожилого и старческого возраста. Мнение экспертов Общества специалистов по сердечной недостаточности, Российской ассоциации геронтологов и гериатров и Евразийской ассоциации терапевтов // Сердечная недостаточность. 2018 (в печати). [Orlova YA.A., Tkacheva O.N., Arutyunov G.P., Kotovskaya YU.V. Osobennosti diagnostiki i lecheniya hronicheskoj serdechnoj nedostatochnosti u pacientov pozhilogo i starcheskogo vozrasta. Mnenie ehkspertov Obshchestva specialistov po serdechnoj nedostatochnosti, Rossijskoj associacii gerontologov i geriatrov i Evrazijskoj associacii terapevtov // Serdechnaya nedostatochnost'. 2018 (v pechati) (in Russian)]. 37. Manzano L., Escobar C., Cleland J.G., Flather M. Diagnosis of elderly patients with heart failure // Eur. J. Heart Fail. 2012. Vol. 14. P.1097–1103. 38. Ponikowski P., Voors A.A., Anker S.D. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure // Eur. Heart J. 2016. Vol. 37. P.2129–2200. 39. Ткачева О.Н., Рунихина Н.К., Воробьева Н.М. и др. Антитромботическая терапия в пожилом и старческом возрасте: согласованное мнение экспертов // Кардиоваскулярная терапия и профилактика. 2017. Т.16. № 3. С.4–33 [Tkacheva O.N., Runihina N.K., Vorob'eva N.M. i dr. Antitromboticheskaja terapija v pozhilom i starcheskom vozraste: soglasovannoe mnenie jekspertov // Kardiovaskuljarnaja terapija i profilaktika. 2017. T.16. № 3. S.4–33 (in Russian)]. 40. Сычев Д.А., Жучков А.В., Богова О.Т., Ильина Е.С. Падения пациентов пожилого и старческого возраста: вклад лекарственных средств // Клиническая геронтология. 2017. Т.23. № 3–4. С.56–64. [Sychev D.A., Zhuchkov A.V., Bogova O.T., Il'ina E.S. Padenija pacientov pozhilogo i starcheskogo vozrasta: vklad lekarstvennyh sredstv // Klinicheskaja gerontologija. 2017. T. 23, № 3–4. S. 56–64 (in Russian)]. 41. Орлова Я.А. Особенности физической реабилитации пожилых пациентов с ХСН // Сердечная недостаточность. 2016. Т.17. № 5. С. 65–375 [Orlova Ja.A. Osobennosti fizicheskoj reabilitacii pozhilyh pacientov s HSN // Serdechnaja nedostatochnost'. 2016. T.17. № 5. S.365–375 (in Russian)]. 42. Boxer R.S., Dauser D.A., Walsh S.J. et al. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure // J. Am. Geriatr. Soc. 2008. Vol. 56. P.454–461. 43. Bischoff-Ferrari H.A., Dietrich T., Orav E.J. et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. // Am. J. Clin. Nutr. 2004. Vol. 80. P.752–758.